PT Wismilak Inti Makmur Tbk (WIIM.JK)
Surabaya, JI, ID
PT Wismilak Inti Makmur Tbk manufactures and sells cigarettes in Indonesia and internationally. The company offers hand-rolled and machine-rolled cigarettes, cigars, filter rods, and other cigarette parts. It also engages in the marketing and distribution of cigarettes. The company markets and sells its products under the Galan Kretek, Wismilak Spesial, Wismilak Slim, Wismilak Satya, Wismilak Diplomat, Galan Prima, Arja, Diplomat Mild, Diplomat Mild Menthol, Diplomat Evo, Wismilak Premium Cigars, and Wismilak Premium Seleccion brands. PT Wismilak Inti Makmur Tbk was founded in 1962 and is headquartered in Surabaya, Indonesia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.67% | -8.71% | -14.70% | -18.75% | -13.56% | +1.88% | +98.17% | +24.05% | +135.51% | +310.35% | +103.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Tobacco: +5.3%+34.3% ★ Q1'26: +18.3% (vs Q1'25)
-
EPS growth Tobacco: +18.8%+40.4% ★ Q1'26: +101.1% (vs Q1'25)
-
FCF margin FCF growth · Tobacco: +9.5%+6.6% ★ Q1'26: +9.0% (vs Q1'25)
-
EBIT margin Tobacco: +20.5%+9.0% Q1'26: +11.9% (vs Q1'25)
-
ROIC Tobacco: +16.0%+19.9% ★ Q1'26: +27.4% (vs Q1'25)
-
Share dilution Tobacco: +0.0%+0.0% Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×0.57× ★ Q1'26: 0.27× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
3.70T
est: 2.22T (+67.0%)
|
4.87T
est: 2.71T (+79.8%)
|
4.75T
est: 4.63T (+2.6%)
|
6.38T
est: 6.11T (+4.5%)
|
6.78T
6.63T – 6.92T
+11.0% YoY
|
7.34T
7.33T – 7.34T
+8.3% YoY
|
| EBITDA |
380.13B
est: 256.32B (+48.3%)
|
652.29B
est: 285.70B (+128.3%)
|
444.31B
est: 487.71B (-8.9%)
|
595.03B
est: 643.30B (-7.5%)
|
713.91B
698.43B – 729.40B
+11.0% YoY
|
772.82B
771.93B – 773.70B
+8.3% YoY
|
| EBIT |
321.92B
est: 217.25B (+48.2%)
|
635.75B
est: 254.44B (+149.9%)
|
389.72B
est: 434.34B (-10.3%)
|
573.85B
est: 572.91B (+0.2%)
|
635.80B
622.00B – 649.59B
+11.0% YoY
|
688.25B
687.47B – 689.04B
+8.3% YoY
|
| Net Income |
249.33B
est: 411.35B (-39.4%)
|
494.31B
est: 394.68B (+25.2%)
|
298.68B
est: 273.17B (+9.3%)
|
419.21B
est: 414.16B (+1.2%)
|
565.20B
506.03B – 642.92B
+36.5% YoY
|
676.75B
634.77B – 778.79B
+19.7% YoY
|
| SGA |
256.88B
est: 188.77B (+36.1%)
|
412.76B
est: 225.47B (+83.1%)
|
431.58B
est: 384.88B (+12.1%)
|
550.58B
est: 507.67B (+8.5%)
|
563.40B
551.18B – 575.62B
+11.0% YoY
|
609.88B
609.19B – 610.58B
+8.3% YoY
|
| EPS |
119.33
est: 198.17 (-39.8%)
|
238.50
est: 190.26 (+25.4%)
|
143.89
est: 131.60 (+9.3%)
|
201.95
est: 199.52 (+1.2%)
|
276.75
243.78 – 309.72
+38.7% YoY
|
340.49
305.80 – 375.18
+23.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-26 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-25 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-22 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-21 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-20 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-19 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-04-30 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-15 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Doni Arya Wibisono | Marketing Manager | — | male |
| Emi Lisawati | Finance & Accounting Manager | — | female |
| Henry Najoan | Chief Personnel | — | male |
| Krisna Tanimihardja | Technical Director & Director | — | — |
| Lucas Firman Djajanto | Director of Finance & Director | — | male |
| Ricky Junaidi | National Sales & Field Marketing Manager | — | male |
| Ronald Walla | President Director | — | male |
| Sugito Winarko | Director of Business Development & Director | — | — |
| Surjanto Yasaputera | Corporate Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WIIM.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
